Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Case on nephrotic syndrome
1. ORATOR: RAYAZ AHMAD BHAT
STUDENT NIPER, GUWAHATI, ASSAM
MODERATOR: DR. (Mrs.) MANGALA LAHKAR
CAC, NIPER, GUWAHATI, ASSAM
MENTOR HOSPITAL: GUWAHATI MEDICAL COLLEGE AND HOSPITAL
4. CHIEF COMPLAINTS
Swelling of both legs from last 2 months
Lower urinary tract symptoms from last 15 days
Respiratory difficulty with on/off cough from last
15 days
5. PATIENT HISTORY
SOCIAL HISTORY
SMOKER: NO
ALCOHOLIC: NO
MEDICAL HISTORY
No history of T2DM or Hypertension
H/o of pain killer for knee joint pain (B/L) 1 month prior
to swelling
No H/o intake of herbal medication
No H/o Haematemesis or Melena
No H/o renal calculi, burning micturation or fever.
15. EPIDEMIOLOGY
Nephrotic syndrome is relatively rare but important
manifestation of kidney disease with a incidence of 3
new cases per 100,000 each year in adults and has
serious complications , caused by a number of
primary and secondary glomerular diseases
Reference : PatientPLUS , Document ID-2505(v24)
20. DISCHARGE MEDICATIONS
TABLET OMNACORTIL (PREDNISOLONE) 20mg 2 tab for
one week
• Followed by 20mg 1 and half tab for 0ne week
• Followed by20 mg 1 tab for 1 week
• Followed by 10mg 1 tab for 10 days
TABLET THYRONORM 75mg OD
TABLET PANTACID 40mg OD BBF
TABLET ATORLIP 20mg OD
TABLET LASIX 60mg BD till swelling subsides
FOLLOW UP
HEMATOLOGY AND NEPHROLOGY OPD EVERY 2 WEEKS
21. PHARMACEUTICAL ISSUES AND SUGGESSIONS
Concurrent use of statins and fibrates increase the risk of
Rhabdomyolysis and Myopathy and the risk is more in eldery
and renal disease patients
SUGGESTION
CREATINE KINASE levels should be monitored regularly
As a general rule any patient given a statin and fibrate should
be told to report any signs of myopathy and possible
RHABDOMYOLYSIS( unexplained muscle pain, tenderness,
weakness or dark urine)
If Myopathy does occur the statin should be stopped
immediately or dose adjusted and monitored closely.
Generally a lower dose of statin with fibrate is recommended
22. •CYP3A4 inhibitors like macrolide antibiotics ,
azole antifungals if required should be prescribed
very cautiously for a patient on statins –High risk
of rhabdomyolysis
Monitoring of liver function is recommended
for all statins to rule out any toxicity to liver
23. High dose of any corticosteriod can produce
hypokalemia via mineralocorticoid action which is
further increased by concurrent administration of
Ferusemide and may produce symptoms of
muscle pain/cramps, confusion , dizziness etc
SUGGESTION
• Increase dietary intake of potassium
• Supplements of Potassium chloride
• Concurrent use of Potassium sparing diuretic
• Dose adjustment
24. PREDNISOLONE may elevate serum TG and LDL levels if used
for prolonged period
SUGGESTION
Close monitoring of lipid levels and dose titration
PREDNISOLONE may also increases blood
coagulability
SUGGESTION
Since the patient is already at risk of
thromboembolism due to loss of anthithrombin-III
close monitoring of PT is necessary to prevent any
complication
25. Response to Prednisolone should be closely
monitored because there are variations in
response to Corticosteroids which include:
Corticosteroid sensitive patients
Corticosteroid resistant patients or Late steroid
responders
Corticosteroid intolerant patients
Corticosteroid dependent patients
26. One of the complication of disease is immune
deficiency due to leakage of immunoglobulin's
and loss of proteins in general making the patient
prone to infections ,so, the patient should be
prescribed appropriate antibiotics and should not
stop taking antibiotic unless told because the
patient is taking PREDNISOLONE which has
IMMUNOSUPRESSANT action further increasing
risk of infections.
27. Concurrent administration of Levothyroxine
with calcium containing products (SHELCAL)
reduces its oral bioavailability by nonspecific
adsorption of levothyroxine to calcium carbonate
at acidic pH
SUGGESTION
Patient should be advised to take Levothyroxine with
a gap of at least 4 hours after or before any calcium
and iron containing products, sucralfate,PPIs
28. Patient was given Tranostat I.V after renal
biopsy to watch for haematuria
SUGGESTION
TRANSTAT being antifibrinolytic and given I.V may
increases the risk of thrombus formation since the
patient is already at risk of thromboembolism
therefore it should be given cautiously and the
patient should be monitored closely for any
thromboembolic complication.
29. Other Suggestions
Chances of embolism increases at rest so, Doctor should
consider this
Patient could be recommended DOPPLER ULTRASOUND to check
any thromboembolic complication
Growth retardation occurs due to loss of proteins and steroid
therapy so the patient should be prescribed suitable
supplements
30. LIFE STYLE MODIFICATIONS
Low fat , low cholesterol diet
limitation of saturated and trans fats
salt restriction
Lean sources of protein
Exercise to prevent thromboembolic complications
Patient should be advised not to take any other medication
without doctors or pharmacists consultation since there are various
complications of the SYNDROME which restricts the use or require
close monitoring of various drugs